Table 3.
Different vaccine administration routes: intradermal vs. subcutaneous lymph node uptake
Patients | mDC × 106 | Administration route | Isotope | Max uptake (%) * |
R.L. (no. 7) | 4 | Intradermal | 99mTc-HMPAO | 0.95 |
G.D. (no. 8) | 4 | Intradermal | 99mTc-HMPAO | 1.02 |
R.L. (no. 7) | 4 | Subcutaneous | 99mTc-HMPAO | 0.30 |
G.D. (no. 8) | 4 | Subcutaneous | 99mTc-HMPAO | 0.37 |
UPTAKE RATIO: intradermal/subcutaneous average: 3 *Maximum uptake = maximum lymph node activity/inoculation site activity at 0 h